Please wait a minute...
文章检索
预防医学  2025, Vol. 37 Issue (9): 959-962    DOI: 10.19485/j.cnki.issn2096-5087.2025.09.020
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
2014—2023年湖州市流行性感冒流行特征分析
胡晓强, 刘艳, 周思凡, 张子喆, 王雨达, 沈建勇
湖州市疾病预防控制中心(湖州市卫生监督所),浙江 湖州 313000
Epidemiological characteristics of influenza in Huzhou City from 2014 to 2023
HU Xiaoqiang, LIU Yan, ZHOU Sifan, ZHANG Zizhe, WANG Yuda, SHEN Jianyong
Huzhou Center for Disease Control and Prevention (Huzhou Institute of Public Health Supervision), Huzhou, Zhejiang 313000, China
全文: PDF(819 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 分析2014—2023年浙江省湖州市流行性感冒(流感)流行特征,为完善流感防控措施提供依据。方法 通过中国疾病预防控制信息系统收集2014—2023年湖州市流感病例资料,采用描述性流行病学方法分析流感发病的人群、地区分布特征;采用年度变化百分比(APC)、平均年度变化百分比(AAPC)分析2014—2023年湖州市流感发病的变化趋势。结果 2014—2023年湖州市报告流感病例83 277例,年均报告发病率为268.68/10万。2014—2023年湖州市流感报告发病率呈上升趋势(AAPC=68.748%,P<0.05),其中2014—2021年呈缓慢上升趋势(APC=31.055%,P<0.05),2021—2023年呈急剧上升趋势(APC=308.782%,P<0.05)。男性流感年均报告发病率为270.72/10万,女性为266.54/10万,差异无统计学意义(P>0.05)。5~<15岁流感年均报告发病率最高,为1 502.77/10万。德清县、长兴县和安吉县流感报告发病率较高,分别为551.44/10万、370.47/10万和175.31/10万。2014—2023年湖州市男性、女性、5~<15岁和15~<25岁人群流感报告发病率变化趋势与全人群一致,各区(县)2021—2023年流感报告发病率变化趋势与湖州市一致。结论 2014—2023年湖州市流感报告发病率整体呈上升趋势,尤其是2021—2023年;无明显性别差异,发病人群以5~<15岁为主,高发地区为德清县。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
胡晓强
刘艳
周思凡
张子喆
王雨达
沈建勇
关键词 流行性感冒发病率平均年度变化百分比    
AbstractObjective To analyze the epidemiological characteristics of influenza in Huzhou City, Zhejiang Province from 2014 to 2023, so as to provide a reference for the improvement of influenza prevention and control measures. Methods The data of influenza cases in Huzhou City from 2014 to 2023 were collected from the China Disease Prevention and Control Information System. Descriptive epidemiological methods were used to analyze the population and regional distribution characteristics of influenza. Annual percent change (APC) and average annual percent change (AAPC) were used to analyze the trend of influenza incidence in Huzhou City from 2014 to 2023. Results A total of 83 277 influenza cases were reported in Huzhou City from 2014 to 2023, with an average annual reported incidence of 268.68/105. From 2014 to 2023, the reported incidence of influenza in Huzhou City showed an upward trend (AAPC=68.748%, P<0.05), with a slow upward trend from 2014 to 2021 (APC=31.055%, P<0.05) and a sharp upward trend from 2021 to 2023 (APC=308.782%, P<0.05). The average annual reported incidence of influenza was 270.72/105 in males and 266.54/105 in females, and the difference was not statistically significant (P>0.05). The average annual reported incidence of influenza in children aged 5-<15 years was 1 502.77/105. The reported incidences of influenza in Deqing county, Changxing county, and Anji county were 551.44/105, 370.47/105, and 175.31/105, respectively. From 2014 to 2023, the trends of reported influenza incidence in males, females, residents aged 5-<15 years, and 15-<25 years were consistent with the whole population. The reported influenza incidence in each district (county) from 2021 to 2023 was consistent with Huzhou City from 2021 to 2023. Conclusions The reported incidence of influenza in Huzhou City showed an overall upward trend from 2014 to 2023, especially from 2021 to 2023. There was no significant gender difference. The majority of the cases were aged 5-<15 years, and the high incidence areas were Deqing County.
Key wordsinfluenza    incidence    average annual percent change
收稿日期: 2025-05-09      修回日期: 2025-08-21      出版日期: 2025-09-10
中图分类号:  R511.7  
基金资助:湖州市科学技术局公益性应用研究项目(2022GYB10); 湖州市疾控中心重点学科:急性传染病学(ZDXK202202); 湖州市医学重点支撑学科(流行病学); 湖州市疾病预防控制中心科技计划项目(KJJH202401)
作者简介: 胡晓强,硕士,医师,主要从事急性传染病研究工作
通信作者: 沈建勇,E-mail:32288746@qq.com   
引用本文:   
胡晓强, 刘艳, 周思凡, 张子喆, 王雨达, 沈建勇. 2014—2023年湖州市流行性感冒流行特征分析[J]. 预防医学, 2025, 37(9): 959-962.
HU Xiaoqiang, LIU Yan, ZHOU Sifan, ZHANG Zizhe, WANG Yuda, SHEN Jianyong. Epidemiological characteristics of influenza in Huzhou City from 2014 to 2023. Preventive Medicine, 2025, 37(9): 959-962.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2025.09.020      或      http://www.zjyfyxzz.com/CN/Y2025/V37/I9/959
[1] SALVADOR GARCÍA C,GIMENO CARDONA C.Influenza:a preventable infection in different populations[J].Enferm Infecc Microbiol Clin(Engl Ed),2023,41(7):387-390.
[2] 刘书珍,孟丽,席佩佩,等.四价流感病毒裂解疫苗安全性和免疫原性评价[J].预防医学,2020,32(11):1091-1095.
LIU S Z,MENG L,XI P P,et al.Safety and immunogenicity of a split-virion quadrivalent influenza vaccine[J].China Prev Med J,2020,32(11):1091-1095.(in Chinese)
[3] JAVANIAN M,BARARY M,GHEBREHEWET S,et al.A brief review of influenza virus infection[J].J Med Virol,2021,93(8):4638-4646.
[4] DAI P X,WANG Q,JIA M M,et al.Driving more WHO-recommended vaccines in the national immunization program:issues and challenges in China[J/OL].Hum Vaccin Immunother,2023[2025-08-21].https://doi.org/10.1080/21645515.2023.2194190.
[5] LI L,LIU Y N,WU P,et al.Influenza-associated excess respiratory mortality in China,2010-15:a population-based study[J].Lancet Public Health,2019,4(9):473-481.
[6] 龚慧,申鑫,严涵,等.2006—2019年中国季节性流感疾病负担估计[J].中华医学杂志,2021,101(8):560-567.
GONG H,SHEN X,YAN H,et al.Estimating the disease burden of seasonal influenza in China,2006-2019[J].NatI Med J China,2021,101(8):560-567.(in Chinese)
[7] 刘艳,沈建勇,刘光涛,等.湖州市法定呼吸道传染病流行特征分析[J].预防医学,2024,36(1):22-25.
LIU Y,SHEN J Y,LIU G T,et al.Epidemiological characteristics of notifiable respiratory infectious diseases in Huzhou City[J].China Prev Med J,2024,36(1):22-25.(in Chinese)
[8] WANG Y D,LIU Y,LIU G T,et al.Analysis of data from two influenza surveillance hospitals in Zhejiang Province,China,for the period2018-2022[J/OL].PLoS One,2024,19(2)[2025-08-21].https://doi.org/10.1371/journal.pone.0299488.
[9] 王远航,富小飞,亓云鹏,等.嘉兴市流行性感冒时空聚集性分析[J].预防医学,2025,37(1):55-58.
WANG Y H,FU X F,QI Y P,et al.Spatio-temporal clustering analysis of influenza in Jiaxing City[J].China Prev Med J,2025,37(1):55-58.(in Chinese)
[10] WU H C,XUE M,WU C,et al.Estimation of influenza incidence and analysis of epidemic characteristics from 2009 to 2022 in Zhejiang Province,China[J/OL].Front Public Health,2023,11[2025-08-21].https://doi.org/10.3389/fpubh.2023.1154944.
[11] YANG M M,GONG S S,HUANG S Q,et al.Geographical characteristics and influencing factors of the influenza epidemic in Hubei,China,from2009 to 2019[J/OL].PLoS One,2023,18(11)[2025-08-21].https://doi.org/10.1371/journal.pone.0280617.
[12] 国家卫生健康委员会.流行性感冒诊疗方案(2018年版修订版)[J].传染病信息,2018,31(6):500-504.
National Health Commission of the People's Republic of China.Guideline for diagnosis and treatment of infuenza(revision 2018)[J].Infect Dis Inf,2018,31(6):500-504.(in Chinese)
[13] OZARAS R,CIRPIN R,DURAN A,et al.Influenza and COVID-19 coinfection:report of six cases and review of the literature[J].J Med Virol,2020,92(11):2657-2665.
[14] CHENG W,YU Z,LIU S,et al.Successful interruption of seasonal influenza transmission under the COVID-19 rapid response in Zhejiang Province,China[J].Public Health,2020,189:123-125.
[15] WANG Q,JIA M M,JIANG M Y,et al.Seesaw effect between COVID-19 and influenza from2020 to 2023 in World Health Organization regions:correlation analysis[J/OL].JMIR Public Health Surveill,2023,9[2025-08-21].https://doi.org/10.2196/44970.
[16] GROHSKOPF L A,BLANTON L H,FERDINANDS J M,et al.Prevention and control of seasonal influenza with vaccines:recommendations of the Advisory Committee on Immunization Practices-United States,2022-23 influenza season[J].MMWR Recomm Rep,2022,71(1):1-28.
[17] 中国疾病预防控制中心.中国流感疫苗预防接种技术指南(2023—2024)[J].中国病毒病杂志,2024,14(1):1-19.
Chinese Center for Disease Control and Prevention.Technical Guidelines for influenza vaccination in China(2023-2024)[J].Chin J Viral Dis,2024,14(1):1-19.(in Chinese)
[1] 李玉荣, 王冬飞, 高媛媛, 蒋园园, 林君英, 肖段段. 2010—2024年萧山区结直肠癌发病趋势分析[J]. 预防医学, 2025, 37(9): 927-931,936.
[2] 李君, 朱婷婷, 胡文雪. 2005—2023年温州市丙型病毒性肝炎流行特征分析[J]. 预防医学, 2025, 37(9): 932-936.
[3] 马珊珊, 赵棋锋, 马岩, 王吉玲, 陈海苗, 方益荣. 2015—2024年绍兴市流行性感冒时空聚集性分析[J]. 预防医学, 2025, 37(9): 945-949.
[4] 李克, 庞志峰, 吴晓虹, 王诚, 何瑶, 唐慧玲. 2007—2024年金华市钩端螺旋体病流行特征分析[J]. 预防医学, 2025, 37(8): 818-821.
[5] 冷雪, 傅淑琴, 舒纪为, 谭启龙, 李科峰. 舟山市带状疱疹首诊病例特征分析[J]. 预防医学, 2025, 37(7): 701-704.
[6] 朱颖, 郑添. 2013—2023年嘉善县居民期望寿命变化[J]. 预防医学, 2025, 37(6): 598-602.
[7] 董沙沙, 项云飞. 2014—2023年余姚市原发性肝癌死亡与疾病负担分析[J]. 预防医学, 2025, 37(6): 603-607.
[8] 马莹, 张文霞, 马金宇, 董军强, 王秀琴, 李文玉, 赵立华. 2014—2023年宁夏流行性感冒时空聚集性分析[J]. 预防医学, 2025, 37(6): 608-611.
[9] 丁哲渊, 杨研, 傅天颖, 鲁琴宝, 王心怡, 吴昊澄, 刘魁, 林君芬, 吴晨. 2024年浙江省法定传染病疫情分析[J]. 预防医学, 2025, 37(5): 433-438,442.
[10] 任露露, 顾嘉昌, 闵艺璇, 张思晨, 乔健健, 肖月, 胡静. 2016—2023年宜兴市脑卒中发病趋势分析[J]. 预防医学, 2025, 37(5): 498-502.
[11] 李慧君, 叶振淼, 樊丽辉, 郑宇航, 谢轶敏, 姜雪霞, 高豪俊, 张默涵, 罗永园. 2015—2023年温州市老年人跌倒死亡趋势与减寿分析[J]. 预防医学, 2025, 37(5): 460-464.
[12] 周沁易, 马涛, 赵跃媛, 王恒学, 吴小清, 丁松宁, 苏晶晶. 2004—2022年南京市法定传染病发病趋势分析[J]. 预防医学, 2025, 37(5): 476-480.
[13] 王洪岩, 任飞林, 刘小琦, 金玫华, 吴振乾. 2009—2023年湖州市HIV/AIDS病例新发现率趋势分析[J]. 预防医学, 2025, 37(4): 395-399.
[14] 叶振淼, 樊丽辉, 姜雪霞, 郑宇航, 张默涵, 罗永园, 谢轶敏, 李慧君, 金茜. 2014—2023年温州市胃癌死亡及减寿趋势分析[J]. 预防医学, 2025, 37(3): 267-271.
[15] 张小乔, 张筱碟, 赵振希, 谢鹏留, 代敏. LSTM、SARIMA和SARIMAX模型预测手足口病发病率的效果比较[J]. 预防医学, 2025, 37(3): 280-284,287.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed